<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://glpchart.com/news/mounjaro-cardiovascular-indication/</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Chart</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-16T17:30:00+10:00</news:publication_date>
      <news:title>FDA gave Mounjaro a heart attack and stroke indication in type 2 diabetes on a trial where it tied Trulicity</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpchart.com/news/amazon-one-medical-glp1-48-states/</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Chart</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-16T17:00:00+10:00</news:publication_date>
      <news:title>Amazon One Medical opened cash-pay GLP-1 visits in 48 states from $39 by message and $59 by video</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpchart.com/news/novo-nordisk-name-change-novo/</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Chart</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-15T10:30:00+10:00</news:publication_date>
      <news:title>Novo Nordisk, the maker of Ozempic and Wegovy, will go by Novo</news:title>
    </news:news>
  </url>
</urlset>
